Evaluating international patient experiences of Public Patient Involvement (PPI) and discussing the potential to embed PPI in Irish healthcare reform.
We have invited some leading patient partners/advocates from Canada and the UK, to share their experiences of public patient involvement across healthcare in the UK and Canada. This is an opportunity to learn from practices in territories where patient involvement is at a much more advanced stage of acceptance and in some cases embedded at the government policy level.
Patient partner and advocate, Carol Munt, will discuss the real value and impact in involving patients as co-producers drawing on her own experiences in the UK where she has worked as a patient partner with the NHS across a number of groups and initiatives. Carol was also a registered nurse so she offers a unique perspective on the evaluation of the impact of patient involvement from a healthcare professional perspective.
We are also delighted to welcome Julie Drury, Strategic Lead – Patient Partnership at the Canadian Foundation for Healthcare Improvement, to the line-up. Prior to joining CFHI, Julie Drury was the chair of Ontario’s first-ever health advisory council, the Patient and Family Advisory Council for the Ontario Ministry of Health and Long-Term Care. In this position, she facilitated and provided the patient and family perspective in health care policy and decision-making. She helped advise the government on key health care priorities that had a real impact on patient care and patient experiences in Ontario. Julie is no stranger to advising health care providers. While managing her daughter’s complex medical needs, Julie mentored other families facing similar challenges and helped them navigate the health care system. She is passionate about partnerships between patients, families, and health care professionals.
And finally, Laura Magahy Executive Director, Sláintecare, will be joining us to discuss future commitments and the proposed framework for patient involvement in Irish healthcare.
Please join us for this important discussion and learning opportunity.
This event was made possible through a combination of IPPOSI resources and a number of unrestricted grants from the following IPPOSI Industry members: Bristol-Meyers Squibb, Janssen Ireland, Novartis Ireland Ltd, Sanofii Aventis Ireland Ltd, Takeda Products Ireland & UCB Pharma Ltd